# Efficacy, Safety and Tolerability Study of Subcutaneous C.E.R.A. in Pre-Dialysis Participants With Chronic Renal Anemia

> **NCT00517881** · PHASE3 · TERMINATED · sponsor: **Hoffmann-La Roche** · enrollment: 29 (actual)

## Conditions studied

- Anemia

## Interventions

- **DRUG:** Methoxy polyethylene glycol-epoetin beta (C.E.R.A.)

## Key facts

- **NCT ID:** NCT00517881
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-06
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 29 (ACTUAL)
- **Why stopped:** The study was terminated due to the slow recruitment rate.
- **Last updated:** 2016-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00517881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00517881, "Efficacy, Safety and Tolerability Study of Subcutaneous C.E.R.A. in Pre-Dialysis Participants With Chronic Renal Anemia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00517881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*